Live Breaking News & Updates on Institute of nuclear medicine
Stay updated with breaking news from Institute of nuclear medicine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The price of a drug for COVID-19 patients developed by India's top defence research body has been fixed at Rs 990 per sachet, news agency ANI reported today quoting unnamed officials. ....
Price of DRDO s 2DG anti-COVID-19 drug fixed at Rs 990, government hospitals to get discount INMAS-DRDO scientists in April 2020, conducted lab experiments with the Centre for Cellular and Molecular Biology (CCMB), Hyderabad. (Image Source: ANI) Updated: May 28, 2021, 03:23 PM IST The 2DG anti-COVID-19 drug by Defence Research and Development Organisation (DRDO) has been priced at Rs 990 per sachet by Dr Reddy s lab. As per ANI, the Central and state government hospitals would be provided with the medicine at a discounted price. 2DG (2 Deoxy-D-glucose) anti-COVID-19 drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of the Defence Research and Development Organisation (DRDO), in collaboration with Hyderabad-based pharma company Dr Reddy s Laboratories (DRL). ....
'Made for the rich': Citizens slam govt for high price of DRDO's 2DG anti-COVID 19 drug freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.
New Delhi [India], May 28 (ANI): Defence Research and Development Organisation's (DRDO) anti-Covid-19 drug will be sold at Rs 990 per sachet by Dr Reddy's Laboratories (DRL), officials said on Friday. The Hyderabad-based pharma company, however, will provide the medicine to Centre and state government at a discounted price. ....
DRDO's anti-Covid drug priced at Rs 990 per sachet; Centre, states to get discounts | India News indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.